Latest publications

Sensitization to Cor a 9 or Cor a 14 has a strong impact on the distribution of thresholds to hazelnut. Masthoff LJN, Blom WM, Rubingh CM, Klemans RJB, Remington BC, Bruijnzeel-Koomen CAFM et al. J Allergy Clin Immunol Pract 2018 May 18

The impact of oral food challenges for food allergy on quality of life: A systematic review. Kansen HM, Le TM, Meijer Y, Flokstra-de Blok BMJ, Welsing PMJ, Van der Ent CK et al. Pediatr Allergy Immunol 2018 Apr 16

Patterns of topical corticosteroids prescriptions in children with asthma. Arabkhazaeli A, Vijverberg SJH, Van der Lee M, Van der Ent CK, Bruijnzeel-Koomen CA, De Bruin-Weller MS et al. Pediatr Dermatol 2018 May; 35(3):378-383

2S protein Ara h 7.0201 has unique epitopes compared to other Ara h 7 isoforms and is comparable to 2S proteins Ara h 2 and 6 in basophil degranulation capacity. Hayen SM, Ehlers AM, Den Hartog Jager CF, Garssen J, Knol EF, Knulst AC et al. Clin. Exp. Allergy 2018 Mar 14

Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs. Bakker DS, Garritsen FM, Leavis HL, Van der Schaft J, Bruijnzeel-Koomen CAFM, Van den Broek MPH et al. J Dermatolog Treat 2018 Mar 28:1-6

Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands. Garritsen FM, Van den Heuvel JM, Bruijnzeel-Koomen CAFM, Maitland-van der Zee AH, Van den Broek MPH, De Bruin-Weller MS et al. J Eur Acad Dermatol Venereol 2018 Feb 27

Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment. Wollenberg A, Ariens L, Thurau S, Van Luijk C, Seegräber M, De Bruin-Weller M et al. J Allergy Clin Immunol Pract 2018 Feb 09

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Knol EF et al. J. Allergy Clin. Immunol. 2018 Apr; 141(4):1523-1526

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study. Van den Reek JMPA, Van Vugt LJ, Van Doorn MBA, Van der Kraaij GE, De Kort WJA, Lucker GPH et al. Acta Derm. Venereol. 2018 Feb 06

Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors. De Bruin-Weller M, Graham NMH, Pirozzi G, Shumel B et al. Br. J. Dermatol. 2018 May; 178(5):1220-1221

Epidemiology of atopic dermatitis in adults: Results from an international survey. Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL et al. Allergy 2018 Jan 10

Parental treatment management skills in paediatric atopic dermatitis. Fieten KB, Bruins FM, Zijlstra WT, Schappin R, Figee L, De Bruijn M et al. Clin. Exp. Dermatol. 2018 Jun; 43(4):461-463

Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergy. Blankestijn MA, Knulst AC, Knol EF, Le TM, Rockmann H, Otten HG et al. Clin Transl Allergy 2017; 7:42

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). De Bruin-Weller M, Thaçi D, Smith CH, Reich K, Cork MJ, Radin A et al. Br. J. Dermatol. 2018 May; 178(5):1083-1101

Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial. Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC et al. JAMA 2017 11 14; 318(18):1798-1809